Nykode Therapeutics to Present at SVB Securities Global Biopharma Conference
07.02.2023 - OSLO, Norway, Feb. 07, 2023 (GLOBE NEWSWIRE) - Nykode Therapeutics ASA (OSE: NYKD), a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel immunotherapies, today announced that its Chief Executive Officer, ...
Agnete Fredriksen Roche Group Oslo Stock Exchange About Nykode Antigen Presenting Cells Adaptive Biotechnologies
Source: wallstreet-online.de